Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bladder Cancer
Data on bladder cancer detailed by B.J. Schmitzdrager and co-authors
April 1st, 2008
According to recent research from Germany, "Painless hematuria has remained a diagnostic challenge in daily urological practice. Key problem in the assessment of these patients is the discrimination between malignant and non-malignant conditions." "In this prospective study the role of immunocytology in the evaluation of patients with hematuria was investigated. Ucyt (R) is a commercially available immunocytological assay based upon microscopical detection of tumor-associated antigens on the membrane of urothelial cells by immunofluorescence. Between October 2000 and July 2007, 301 consecutive patients with a first episode of painless hematuria without prior...
Source: Cancer Weekly (2008-04-01)
|
